CNQ · BETR.CN
BetterLife Pharma Inc.
CA$0.25+CA$0.01 (+4.17%)
BetterLife Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.65% below the high.
Loading market information…
TSXV · DHB.V · CAD
Stock price, earnings
Quote as of Oct 28, 2026, 07:27 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Delivra Health Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Delivra Health Brands Inc.’s next earnings report is currently expected on Nov 10, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Delivra Health Brands Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| CA$0.05 |
| CA$3.59M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.25+CA$0.01 (+4.17%)
BetterLife Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.65% below the high.
CA$0.13CA$0.00 (0.0%)
Captiva Verde Wellness Corp.’s quoted price sits in the upper half of its reported 52-week range, 13.33% below the high.
CA$0.35CA$0.00 (0.0%)
Mydecine Innovations Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.79CA$0.00 (0.0%)
Crescita Therapeutics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
CA$0.04-CA$0.02 (-27.27%)
Lobe Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
CA$0.04-CA$0.01 (-22.22%)
CLS Holdings USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.16% below the high.
CA$0.52+CA$0.03 (+5.05%)
Avant Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.4% below the high.
CA$0.02+CA$0.01 (+50.0%)
Blueberries Medical Corp.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
